One-two punch could be key in treating blindness

April 9, 2013
András Komáromy and colleagues discovered that a combination therapy restored vision in dogs with an inherited retinal disorder. Credit: Photo by Tom Genarra

Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness. While their study focused on man's best friend, the treatment could help restore vision in people, too.

Published in the journal Molecular Therapy, the study builds on earlier work by Michigan State University veterinary ophthalmologist András Komáromy and colleagues. In 2010, they restored day vision in dogs suffering from achromatopsia, an inherited form of total , by replacing the associated with the condition.

While that treatment was effective for most younger dogs, it didn't work for canines older than 1 year. Komáromy began to wonder if the older dogs' cones – the in the retina that process daylight and color – might be too worn out.

" only works if the nonfunctional cell that is primarily affected by the disease is not too degenerated," he said. "That's how we came up with the idea for this new study. How about if we selectively destroy the light-sensitive part of the cones and let it grow back before performing gene therapy? Then you'd have a younger, less degenerated cell that may be more responsive to therapy."

So, Komáromy and colleagues recruited more dogs with achromatopsia between 1 and 3 years old. To test their theory, they again performed gene therapy but first gave some of the dogs a dose of a protein called CNTF, which the produces to keep cells healthy. At a high enough dose, its effect on is a bit like pruning flowers: It partially destroys them, but allows for new growth.

"It was a long shot," said Komáromy, associate professor in MSU's Department of Small Animal .

But it worked.

"We were just amazed at what we found," he said. "All seven dogs that got the combination treatment responded, regardless of age."

While achromatopsia is quite rare, Komáromy said it's a good model disease for other disorders affecting the photoreceptors, conditions that constitute a major cause of incurable blindness in dogs and humans. Those disorders affect individuals of both species in much the same way, so the combination treatment's promise isn't just for Fido.

"Based on our results we are proposing a new concept of retinal therapy," he said. "One treatment option alone might not be enough to reverse vision loss, but a combination therapy can maximize therapeutic success."

Explore further: First clinical trial of gene therapy for childhood blindness

Related Stories

First clinical trial of gene therapy for childhood blindness

May 1, 2007

The first clinical trial to test a revolutionary treatment for blindness in children has been announced by researchers at UCL (University College London). The trial, funded by the Department of Health, is the first of its ...

Gene therapy cures canines of inherited form of day blindness

April 21, 2010

Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy ...

Stem cell technique offers new potential to treat blindness

September 22, 2010

(PhysOrg.com) -- University College London scientists are pioneering a stem cell treatment to replace diseased parts of the retina, which could lead to a future treatment for retinal diseases that affect around 3,000 children ...

New twist in a blindness-causing disease gene found

September 21, 2011

After more than three decades of research, University of Pennsylvania veterinarians and vision-research scientists, with associates at Cornell University, have identified a gene responsible for a blindness-inducing disease ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.